RNA splicing analysis in genomic medicine

Area of Science:

• Genomics
• Molecular Biology
• Bioinformatics

Background:

• Next-generation sequencing (NGS) increases identified genetic variants, but current analysis misses splicing effects.
• Aberrant splicing is linked to various diseases, necessitating accurate variant interpretation.
• Novel splice-switching therapies highlight the need for precise splicing analysis.

Purpose of the Study:

• To address the limitations of current bioinformatic pipelines in detecting splicing effects of genetic variants.
• To explore advanced methods for accurate interpretation of splicing variants in clinical diagnostics.
• To investigate the potential of RNA-sequencing (RNA-seq) and machine learning for understanding the 'splicing code'.

Main Methods:

• Review of current bioinformatic analysis pipelines for genetic variants.
• Discussion of limitations in in silico splicing prediction tools.
• Exploration of RNA-sequencing (RNA-seq) as a diagnostic tool.
• Consideration of data science and machine learning approaches.

Main Results:

• Current bioinformatic tools lack sensitivity and specificity for splicing variant detection.
• RT-PCR, minigene assays, and reporter assays offer targeted or detailed splicing analysis but are resource-intensive.
• RNA-sequencing (RNA-seq) shows promise as a rapid diagnostic method for splicing effects.

Conclusions:

• Accurate interpretation of splicing variants is crucial for diagnosing genetic diseases and guiding novel therapies.
• Integrating data science and machine learning with RNA-seq could unlock the 'splicing code' for improved clinical diagnostics.
• Further development is needed to enhance the diagnostic utility of RNA-seq for splicing variant analysis.